| J0897 | Injection, denosumab, 1 mg | 7,390 | $20 | $140.5K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 22,800 | $1 | $91.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 680 | $110 | $72.1K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 5,750 | $10 | $63.3K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,060 | $30 | $53.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 210 | $120 | $25.7K |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 60 | $410 | $25.6K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 340 | $70 | $22.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 140 | $150 | $21K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 90 | $180 | $16.9K |